The goal of this study is to build a clinical research network that can support treatment and prevention studies, and to better understand the biomarkers of FTD.
The study is designed to understand how the brains of the people with Alzheimer's Disease respond to high insulin levels. Previous research has shown that the brains of people with Alzheimer's Disease may be "resistant" to insulin. Findings from this study will help expand our understanding of Alzheimer's Disease and may even help us learn about new ways to prevent or treat the disease.
The purpose of the study is to develop ways for understanding brain changes effecting memory and thinking that occur with age.
The purpose of this study is to determine the presence of the protein Tau in the brain in a variety of populations, ranging from healthy adults to those diagnosed with a neurodegenerative disease.
The goal of the study is to examine olfactory function (or the sense of smell) in healthy individuals and in preclinical and clinical subjects with Alzheimer's Disease, Dementia with Lewy Bodies, or Frontotemporal Dementias.
The purpose of this research study is to look at brain connectivity in a variety of people with memory problems, including people with complaints about their memory and people diagnosed with a neurodegenerative disease, including Alzheimer’s disease (AD), fronto-temporal dementia (FTD), and mild cognitive impairment (MCI).
This study examines the effect of cognitive enhancement programs on age related changes in memory and attention.
This study will use PET neuroimaging to determine the amount of tau protein in the brain and to explore the relationship between presence of tau and clinical course of Parkinson's disease (PD) and dementia with Lewy bodies (DLB).
The goal of this study is to determine whether there is a preclinical FTD stage where those at risk for FTD have changes in their brain structure but no symptoms of FTD.
The purpose of the study is to see if there are brainwave abnormalities in the brains of people with Alzheimer’s Disease and determine whether there is a distinct brainwave signature for Alzheimer’s Disease.